HCPLive Network

Autoimmune Diseases Cost US More Than $100 Billion Annually

A report recently released by the American Autoimmune Related Diseases Association (AARDA), notes that more than 50 million Americans are affected by an autoimmune disease such as rheumatoid arthritis, psoriasis, and lupus. The report discusses the rising incidence of autoimmune diseases, outlines the increasing costs associated with these conditions, and offers policy recommendations designed to improve care.

The AARDA report “The Cost Burden of Autoimmune Disease: The Latest Front in the War on Healthcare Spending,” says that “autoimmune diseases have been reported to be on the rise in the U.S. and around the world, making this poorly understood category of disease a public health crisis at levels comparable to heart disease and cancer.” Citing a “severe lack of awareness” among the general public and medical community, “unequal allocation of research funding and focus,” and “a lack of coordinated care and standardized diagnostic tests,” the report claims that “the associated cost of autoimmune diseases has become a significant portion of the rising cost of healthcare in the US.”

Although the AARDA estimates that 50 million Americans have an autoimmune disease, the report notes that there is insufficient epidemiological data available to determine “the full direct and indirect cost to the overall health care system due to autoimmune disease.” The National Institutes of Allergy and Infectious Diseases (NIAID) has estimated that the cost of treating autoimmune disease in the US is greater than $100 billion annually, a figure that the AARDA report says “is likely a vast understatement of the true costs of autoimmune disease as the annual costs of only seven of the 100+ known autoimmune diseases -- Crohn’s disease, ulcerative colitis, systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and scleroderma -- are estimated through epidemiological studies to total from $51.8-$70.6 billion annually.”

The report estimates that the annual direct cost of treating rheumatoid arthritis in the US is $10.9 billion, with indirect costs totaling $8.4 billion. It cites a survey published in the Journal of Rheumatology that found that “not only are estimated average earnings decreased in RA patients from $18,409 to $13,900 per year, but additionally the number of jobs patients could perform [has] dropped from 11.5 million to 2.6 million.” Thus, 50% of patients with RA become unable to work within ten years of disease onset.

Citing the publication “The Burden of Musculoskeletal Diseases,” the AARDA report says that RA patients “accounted for 1.1 million ambulatory care visits in 2004, representing 2.4% of the 44.2 million non-injury emergency room visits with a primary diagnosis of Arthritis and Other Rheumatic Conditions (AORC).” RA patients also accounted for 2% (18,000) of the 922,100 non-federal, short stay hospitalizations for AORC in 2004.

The direct and indirect costs of RA and other autoimmune diseases mean that “the importance of an early diagnosis and onset of treatment is key in minimizing life altering complications that can occur as a result of autoimmune disease… Therefore, obtaining the recommended care for autoimmune disease patients is paramount.”

The report also states that “the addition of new cutting edge biologic treatments for autoimmune patients requires an even higher level of coordination and expertise from physicians as these treatments, while revolutionary as lifesaving and quality of life-enhancing tools, must be heavily monitored for short-term and long-term adverse side effects and dosage issues.”

In a news release accompanying the release of the report, AARDA Executive Director Virginia Ladd offered several recommendation for reducing the costs associated with rheumatoid arthritis and other autoimmune diseases and improving the care delivered to patients:
  • Streamline the diagnosis process which right now can take years and numerous doctor visits.
  • Create a new medical specialist – the autoimmunologist.
  • Coordinate and manage patient care through community-based autoimmune triage centers rather than costly hospital emergency room visits and extended hospital stays.
  • Focus and expand federal research funding for autoimmune disease that leads to better diagnostic tools and new treatment options.
  • Increase awareness amongt the general public about autoimmunity and autoimmune disease so they can be better advocates for their own health and their loved ones.

HCPLive wants to know:

Do you agree with the AARDA that creating the new medical specialty of “autoimmunologist” is essential to improving the care of patients with rheumatoid arthritis and other autoimmune diseases?

Is there a lack of awareness of the true disease burden of RA and other autoimmune diseases among medical professionals? If so, to what do you attribute this deficiency?

How harmful is prolonged time-to-diagnosis/delayed diagnosis? Does something other than the complexity of diagnosing diseases with overlapping symptoms account for this phenomenon?

Leave a comment below!

Further Reading
A study in rats hints that exposure to dim light at night may make human breast cancer tumors resistant to doxorubicin. The study was presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Sept. 28 to Oct. 1 in New Orleans.
The risk of medical professional liability claims alleging failure to screen for esophageal cancer is not a reason to screen for esophageal cancer, according to a research letter published in the Oct. 1 issue of the Journal of the American Medical Association.
Citing a “public health epidemic” of death and addiction related to use of prescription opioids, the American Academy of Neurology (AAN) calls for a multi-pronged approach to curbing prescriptions. But the group stresses that finding ways to help patients in chronic pain is worthwhile and difficult.
A patient at Texas Health Presbyterian Hospital has tested positive for the deadly virus.
Kevin Skole, MD is a board-certified gastroenterologist practicing in central New Jersey, part of the gastroenterology division of Princeton Healthcare Affiliated Physicians, a multi-specialty medical practice based out of the University Medical Center of Princeton at Plainsboro (see www.princetonhcs.org). He discusses the increased incidence, risk factors, and prevention of Clostridium Difficile (C. diff) infection.
There is a wide variety of evidence to support benefits of low-fat diets versus low carbohydrate diets and vice versa. As of today, no one can tell us with certainty whether the well-worn dictum "calories in calories out" is really true. The National Weight Control Registry data give us some confidence in recommending that to lose weight most people need to alter their diet to reduce calories, and need to exercise on a near-daily basis.
Cannabis users who acknowledge their problem and report withdrawal symptoms are likely to increase abstinence over a 12-month period, according to research published in the Journal of Addiction Medicine.
More Reading